Herein, we sought to construct risk calculators based on cancer biomarkers, enabling more accurate discrimination among patients which may benefit from active interventions.Ki67 immunoscore, GSTP1 and KLF8 promoter methylation levels (<sup>me</sup>) were assessed in PCa tissues. The gene discussed is GSTP1; the disease is cancer.